India Life Sciences completed a $15.8m investment in SRV Hospitals.

InvAscent, a private equity firm, completed a $15.8m investment in SRV Hospitals, an Indian healthcare provider operating a chain of advanced multispecialty hospitals focused on high-acuity tertiary care. “We are proud to partner with SRV Hospitals. SRV’s differentiated care model around critical care and a strong leadership team make them a standout in India’s evolving healthcare landscape,” Dr Jeevak Gupta, InvAscent Director.